409 related articles for article (PubMed ID: 15694923)
1. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
[TBL] [Abstract][Full Text] [Related]
2. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
[TBL] [Abstract][Full Text] [Related]
3. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
Woodruff-Pak DS; Tobia MJ; Jiao X; Beck KD; Servatius RJ
Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
Goh CW; Aw CC; Lee JH; Chen CP; Browne ER
Drug Metab Dispos; 2011 Mar; 39(3):402-11. PubMed ID: 21148081
[TBL] [Abstract][Full Text] [Related]
6. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
Samochocki M; Höffle A; Fehrenbacher A; Jostock R; Ludwig J; Christner C; Radina M; Zerlin M; Ullmer C; Pereira EF; Lübbert H; Albuquerque EX; Maelicke A
J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
[TBL] [Abstract][Full Text] [Related]
7. Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Giorgetti M; Gibbons JA; Bernales S; Alfaro IE; Drieu La Rochelle C; Cremers T; Altar CA; Wronski R; Hutter-Paier B; Protter AA
J Pharmacol Exp Ther; 2010 Jun; 333(3):748-57. PubMed ID: 20194526
[TBL] [Abstract][Full Text] [Related]
8. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system.
Zivin M; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase.
Nakahata K; Kinoshita H; Hama-Tomioka K; Ishida Y; Matsuda N; Hatakeyama N; Haba M; Kondo T; Hatano Y
Anesthesiology; 2008 Jul; 109(1):124-9. PubMed ID: 18580182
[TBL] [Abstract][Full Text] [Related]
12. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
13. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis.
Kotani S; Yamauchi T; Teramoto T; Ogura H
Chem Biol Interact; 2008 Sep; 175(1-3):227-30. PubMed ID: 18501884
[TBL] [Abstract][Full Text] [Related]
14. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Dajas-Bailador FA; Heimala K; Wonnacott S
Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
[TBL] [Abstract][Full Text] [Related]
15. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
16. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.
Woodruff-Pak DS; Vogel RW; Wenk GL
Neuroscience; 2003; 117(2):439-47. PubMed ID: 12614684
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Enz A; Gentsch C
Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.
Barnes CA; Meltzer J; Houston F; Orr G; McGann K; Wenk GL
Neuroscience; 2000; 99(1):17-23. PubMed ID: 10924948
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores GM; Huger FP; Petko W; Mutlib AE; Camacho F; Rush DK; Selk DE; Wolf V; Kosley RW; Davis L; Vargas HM
J Pharmacol Exp Ther; 1996 May; 277(2):728-38. PubMed ID: 8627552
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
